Literature DB >> 27413282

Parasites and immunotherapy: with or against?

Hossein Yousofi Darani1, Morteza Yousefi2, Marzieh Safari3, Rasool Jafari4.   

Abstract

Immunotherapy is a sort of therapy in which antibody or antigen administrates to the patient in order to treat or reduce the severity of complications of disease. This kind of treatment practiced in a wide variety of diseases including infectious diseases, autoimmune disorders, cancers and allergy. Successful and unsuccessful immunotherapeutic strategies have been practiced in variety of parasitic infections. On the other hand parasites or parasite antigens have also been considered for immunotherapy against other diseases such as cancer, asthma and multiple sclerosis. In this paper immunotherapy against common parasitic infections, and also immunotherapy of cancer, asthma and multiple sclerosis with parasites or parasite antigens have been reviewed.

Entities:  

Keywords:  Asthma; Cancer; Immunotherapy; Multiple Sclerosis; Parasite; Parasitic diseases

Year:  2014        PMID: 27413282      PMCID: PMC4927515          DOI: 10.1007/s12639-014-0533-4

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  106 in total

Review 1.  Immunotherapy of Trypanosoma cruzi infections.

Authors:  N Chamond; N Coatnoan; P Minoprio
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2002-10

2.  A new modular protein of Cryptosporidium parvum, with ricin B and LCCL domains, expressed in the sporozoite invasive stage.

Authors:  Fabio Tosini; Alessia Agnoli; Raffaella Mele; Maria Angeles Gomez Morales; Edoardo Pozio
Journal:  Mol Biochem Parasitol       Date:  2004-03       Impact factor: 1.759

3.  Cloning and expression of cDNA encoding an antigenic Cryptosporidium parvum protein.

Authors:  M C Jenkins; R Fayer
Journal:  Mol Biochem Parasitol       Date:  1995-04       Impact factor: 1.759

4.  A new therapeutic strategy for malaria: targeting T cell exhaustion.

Authors:  Gordon J Freeman; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2012-01-19       Impact factor: 25.606

5.  Immunotherapy in vaginal trichomoniasis--therapeutic and prophylactic effects of the vaccine SolcoTrichovac.

Authors:  F Bonilla-Musoles
Journal:  Gynakol Rundsch       Date:  1984

6.  Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.

Authors:  L E Perryman; S J Kapil; M L Jones; E L Hunt
Journal:  Vaccine       Date:  1999-04-23       Impact factor: 3.641

7.  Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a beta-mannosylated glycolipid.

Authors:  M W Riggs; M R McNeil; L E Perryman; A L Stone; M S Scherman; R M O'Connor
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  Is Necator americanus approaching a mutualistic symbiotic relationship with humans?

Authors:  D I Pritchard; A Brown
Journal:  Trends Parasitol       Date:  2001-04

9.  Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.

Authors:  A W Cheever; M E Williams; T A Wynn; F D Finkelman; R A Seder; T M Cox; S Hieny; P Caspar; A Sher
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

Review 10.  Antibody-based therapies for emerging infectious diseases.

Authors:  A Casadevall
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

View more
  1 in total

Review 1.  How the gut parasitome affects human health.

Authors:  Gianluca Ianiro; Andrea Iorio; Serena Porcari; Luca Masucci; Maurizio Sanguinetti; Carlo Federico Perno; Antonio Gasbarrini; Lorenza Putignani; Giovanni Cammarota
Journal:  Therap Adv Gastroenterol       Date:  2022-04-30       Impact factor: 4.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.